Skip to main content

Table 2 HIV parameters at first AMI episode

From: Increased mortality after a first myocardial infarction in human immunodeficiency virus-infected patients; a nested cohort study

  SHCS
  HIV-positive subjects
  N Total  
Transmission risk category 133  
Heterosexual intercourse   42 (32)
Injection drug use   20 (15)
Men-who-have-sex-with-men   61 (46)
Other/unknown   10 (7)
Time since HIV diagnosis (years) 124 12 (8–18)
Patients with viral load <40 copies per mL 123 95 (77)
CD4 cell count per mm3 129 462 (347–701)
Antiretroviral treatment at the first episode of AMI   
Antiretroviral naïve 133 1 (1)
Not naïve, but not currently on antiretroviral drugs 133 12 (7)
On antiretroviral drugs 133 120 (90)
Antiretroviral regimen containing abacavir 120 51 (43)
Exposure to antiretroviral treatments (previous and current)   
Patients on PI (previous or current) 132 113 (85.6)
Median duration of PI therapy (years) 113 5.6 (3.5–9.4)
Patients under NNRTI (previous or current) 132 88 (86)
Median duration of NNRTI therapy (years) 88 3.5 (0.6–5.9)
Patients on NRTI (previous or current) 132 126 (95)
Median duration of NRTI therapy (years) 126 (6.7–15.1)
  1. Data are no. (%) of subjects or median (interquartile range). PI, protease inhibitors; NNRTI, non-nucleoside reverse-transcriptase inhibitors; NRTI, nucleoside reverse-transcriptase inhibitors.